Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis-Reference-Cited by-同舟云学术

Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis

Published:2018-06-22 Issue:6 Volume:13 Page:e0198457
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

de Freitas Maiara Brusco,Moreira Emilia Addison Machado^ORCID,Tomio Camila,Moreno Yara Maria Franco,Daltoe Felipe Perozzo,Barbosa Eliana,Ludwig Neto Norberto,Buccigrossi Vittoria,Guarino Alfredo

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Microbial contact during pregnancy, intestinal colonization and human disease;S Rautava;Nat Rev Gastroenterol Hepatol,2012

2. Gut microbiota in preterm infants: assessment and relevance to health and disease;JE Berrington;Arch Dis Child Fetal Neonatal Ed,2013

3. Development of the human infant intestinal microbiota;C Palmer;PLoS Biol,2007

4. Human gut microbiome viewed across age and geography;T Yatsunenko;Nature,2012

5. Association between breast milk bacterial communities and establishment and development of the infant gut microbiome;PS Pannaraj;JAMA Pediatr,2017

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of high-dose cholecalciferol (vitamin D3) and inulin prebiotic on intestinal and airway microbiota in adults with cystic fibrosis: A 2 × 2 randomized, placebo-controlled, double-blind pilot study;Journal of Clinical & Translational Endocrinology;2024-09

2. Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis;Journal of Cystic Fibrosis;2024-05

3. Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D trial) in adults with cystic fibrosis;Contemporary Clinical Trials Communications;2024-04

4. Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor;mBio;2024-02-14

5. Intestinal Bacteroides modulates inflammation, systemic cytokines, and microbial ecology via propionate in a mouse model of cystic fibrosis;mBio;2024-02-14